RxDoctor Payments Data

Charissa Farris

Orthopaedic Surgery · San Jose, CANPI 1023227733

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Biotissue Holdings Inc. at 24.1% of the total. Reporting peaked in 2021 at $4,780 and has fallen 99.6% since, to $18 in 2025.

$8,210in general payments, 2019–2025

Across 88 payments — averaging $93.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$2K
  • Arthrex$1K
  • Impactortho, Inc.$1K
  • Stryker$1K
  • Musculoskeletal Transplant Foundation Inc.$763
  • Amgen$261
  • plus $1K from 14 others

What the payments were for

  • Travel & lodging$92111%
  • Food & beverage$4,88860%
  • Education$2,40029%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,210 in reported general payments places this provider in the 65th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Other orthopaedic surgery in San Jose

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →